Target intelligence / Profile preview

RNA, U6 small nuclear 206, pseudogene (RNU6-206P)

Target
RNU6-206P
Molecular classification
Other, Pseudogene (non-coding RNA pseudogene)
01

Overview

RNU6-206P is a human pseudogene related to the U6 small nuclear RNA family, which are critical components of the spliceosome—the complex responsible for pre-mRNA splicing[1][3][5]. Unlike canonical U6 snRNA, which is highly conserved and functionally essential for spliceosome activity and gene expression regulation, pseudogene copies like RNU6-206P lack coding ability and are not known to be transcribed into functional RNAs. Pseudogene formation in the U6 family has been attributed to retrotransposition and template switching mechanisms[5][7]. Although U6 pseudogenes can sometimes be transcribed or have regulatory influence, RNU6-206P is not implicated in any biological process, disease role, or therapeutic targeting[2][7][9]. Their presence in the genome mainly reflects evolutionary processes and retrotransposon dynamics[7][9]. In summary: RNU6-206P is a non-coding RNA pseudogene, not a therapeutically relevant molecule, receptor, or biological target. It appears in gene databases due to its relationship to the U6 snRNA family, but does not serve as a functional protein/RNA nor a drug target and its mention within target lists likely reflects misclassification or confusion between functional and pseudogene copies[2][7][9].

Other names
RNU6-206P
02

Mechanism of action

None. There are no drugs or mechanisms targeting this molecule

03

Biological functions

None. Pseudogenes generally have no known biological function; however, very rarely some pseudogenes show regulatory activity, but no such function has been described for RNU6-206P
04

Disease associations

None. There is no evidence or literature supporting a direct role in disease
05

Safety considerations

None relevant. Pseudogenes do not present known safety or therapeutic challenges; the only possible issue is confusion with functional snRNAs in experimental design
06

Interacting drugs

None. No drugs are known to interact with this pseudogene as it is non-functional and not expressed as a protein or functional RNA
07

Biomarkers

None. It is not used as a biomarker for patient selection or monitoring

Beyond the preview

Go deeper on RNA, U6 small nuclear 206, pseudogene (RNU6-206P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 206, pseudogene (RNU6-206P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call